Developing new RNA vaccine formulations to target non-enveloped viruses and boost mucosal responses
Vaccine Insights 2024; 3(6), 207–215
DOI: 10.18609/vac.2024.033
Published: 10 October
Interview
Jesse Erasmus
Jesse Erasmus, Director of Virology, HDT Bio, joins Charlotte Barker, Commissioning Editor, Vaccine Insights, to discuss developing an RNA vaccine for enterovirus D68, leveraging mucosal immunity, and strategies for improving tolerability in RNA vaccine formulations.